In the indirect immunofluorescence assay for detecting antibodies, which component is labeled with a fluorescent tag to visualize bound antibodies?

• A. Fluorescein-labeled anti-human immunoglobulin
• B. A monoclonal antibody coated on the slide
• C. The patient serum itself
• D. The target antigen fixed to the slide

Answer: (A)

In indirect immunofluorescence, the fluorescent signal comes from a secondary antibody that recognizes human antibodies. After the patient's serum antibodies bind to the antigen immobilized on the slide, a fluorescein-labeled anti-human immunoglobulin is added. This secondary antibody binds to those patient antibodies and carries the fluorescent tag, making the binding visible under a fluorescence microscope. The label isn’t on the patient serum itself or on the target antigen; the slide simply provides the binding site, and the fluorescence comes from the secondary antibody that detects the primary antibodies. This also explains the amplification: multiple secondary antibodies can bind to a single primary antibody, increasing the signal.